pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Apr 30·1 min read
save

Novartis unveils North Carolina factory as final new build in $23B US expansion

Novartis on Thursday revealed its plans to build another factory in the US, with the Swiss drugmaker noting that it has now allocated every dollar of its $23 billion promise to expand ...

Apr 30, 2026·read at Endpoints ↗

April 30, 2026 07:00 AM EDT PharmaManufacturing No­var­tis un­veils North Car­oli­na fac­to­ry as fi­nal new build in $23B US ex­pan­sion Anna Brown News Reporter No­var­tis on Thurs­day re­vealed its plans to build an­oth­er fac­to­ry in the US, with the Swiss drug­mak­er not­ing that it has now al­lo­cat­ed every dol­lar … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

source

Reporting by Endpoints.

read at Endpoints ↗
84 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
NOVARTIS2Sionna Therapeutics, Inc.

related stories

  • Jul 17Dimerix buys a kidney injury drug; Arpeggio appears to be winding downEndpoints
  • May 13#ASGCT26: Tessera reveals strongest data yet for in vivo sickle cell therapyEndpoints
  • May 12EU reaches provisional deal on Critical Medicines ActEndpoints
  • May 12FDA Commissioner Makary resignsEndpoints
  • May 8Post–T-DXd Sacituzumab Govitecan Plus Trastuzumab Yields Low ORR in HER2+ Metastatic Breast Canceronclive